Skip to Content
Merck
  • Human cerebral organoids reveal progenitor pathology in EML1-linked cortical malformation.

Human cerebral organoids reveal progenitor pathology in EML1-linked cortical malformation.

EMBO reports (2022-03-16)
Ammar Jabali, Anne Hoffrichter, Ana Uzquiano, Fabio Marsoner, Ruven Wilkens, Marco Siekmann, Bettina Bohl, Andrea C Rossetti, Sandra Horschitz, Philipp Koch, Fiona Francis, Julia Ladewig
ABSTRACT

Malformations of human cortical development (MCD) can cause severe disabilities. The lack of human-specific models hampers our understanding of the molecular underpinnings of the intricate processes leading to MCD. Here, we use cerebral organoids derived from patients and genome edited-induced pluripotent stem cells to address pathophysiological changes associated with a complex MCD caused by mutations in the echinoderm microtubule-associated protein-like 1 (EML1) gene. EML1-deficient organoids display ectopic neural rosettes at the basal side of the ventricular zone areas and clusters of heterotopic neurons. Single-cell RNA sequencing shows an upregulation of basal radial glial (RG) markers and human-specific extracellular matrix components in the ectopic cell population. Gene ontology and molecular analyses suggest that ectopic progenitor cells originate from perturbed apical RG cell behavior and yes-associated protein 1 (YAP1)-triggered expansion. Our data highlight a progenitor origin of EML1 mutation-induced MCD and provide new mechanistic insight into the human disease pathology.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-TRA-1-81 Antibody, clone TRA-1-81, clone TRA-1-81, Chemicon®, from mouse
Sigma-Aldrich
Monoclonal Anti-MEIS2 antibody produced in mouse, clone 1H4, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-TRA-1-60 Antibody, clone TRA-1-60, clone TRA-1-60, Chemicon®, from mouse